Article

LASIK Xtra gets CE approval

Avedro Inc.’s proprietary LASIK Xtra procedure has received CE mark approval. LASIK Xtra is a 2-minute corneal crosslinking procedure used in conjunction with standard LASIK to restore the biomechanical integrity and strength to the cornea after a LASIK procedure.

Waltham, MA-Avedro Inc.’s proprietary LASIK Xtra procedure has received CE mark approval. LASIK Xtra is a 2-minute corneal crosslinking procedure used in conjunction with standard LASIK to restore the biomechanical integrity and strength to the cornea after a LASIK procedure.

LASIK Xtra has been successfully used in thousands of LASIK surgeries outside the United States.

“Crosslinking within a LASIK procedure using LASIK Xtra is simple, fast and safe,” said A. John Kanellopoulos, MD, a member of Avedro’s medical advisory board. “In studies we’ll be reporting at ASCRS in April, we’ve found that after almost 2 years of follow-up, [patients with hyperopia] appear to have a completely different clinical course if we employ prophylactic crosslinking in their LASIK procedures. Hyperopic LASIK typically regresses more than myopic LASIK.”

LASIK Xtra combines riboflavin ophthalmic solution (VibeX) with its UVA irradiation system (KXL System) to achieve accelerated corneal crosslinking during a LASIK procedure.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.